NCT00064285View on ClinicalTrials.gov

Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 30, 2003

Conditions
Leukemia
Interventions
DRUG

alvocidib

DRUG

imatinib mesylate

Trial Locations (4)

21231

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

23298

Massey Cancer Center at Virginia Commonwealth University, Richmond

44106-5047

Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University, Cleveland

19104-4283

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Virginia Commonwealth University

OTHER

NCT00064285 - Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter